Legal Representation
Attorney
Steven L. Nichols
USPTO Deadlines
Application History
44 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 23, 2023 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
May 23, 2023 | MAB1 | E | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | Loading... |
May 23, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 23, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 23, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 23, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 23, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
May 22, 2023 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
May 18, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
May 18, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
May 18, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 18, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
May 18, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
May 18, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Apr 28, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 28, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Apr 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 27, 2023 | ISMR | Z | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST | Loading... |
Apr 27, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Apr 24, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Apr 24, 2023 | LOPT | I | LETTER OF PROTEST EVIDENCE FORWARDED | Loading... |
Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 28, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 28, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 28, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Feb 27, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 27, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 27, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 27, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Dec 15, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 4, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 4, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 4, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 8, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 8, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 8, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 8, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
May 31, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 12, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Oct 11, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 28, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and drugs for the treatment of diabetes; pharmaceutical preparations and drugs for the treatment of high blood pressure
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific and technological services, namely, biological and pharmaceutical research and development, namely, research and development related to treatment of disease
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the words "GOEGOE PHARM. CO." in black under a shield outlined in blue. On top of the shield sits a red oval outlined in gold enclosing the white letters "O.S.I." and four quadrants, one of which is blue with white stars, one of which is gold with a red cross, one of which has red and white horizontal stripes, and one of which is gold with two red pine trees. Below the shield is a horizontal red ribbon that is outlined in gold on the front and is blue on the reverse side and curls up both sides of the shield.
Color Claim
The color(s) red, blue, white, gold, and black is/are claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARM. CO."